Back to results
US 12,708,750 B2Granted
Core-shell microneedle platform for transdermal and pulsatile drug/vaccine delivery and method of manufacturing the same
AssigneeUniversity of Connecticut
InventorsThanh D. Nguyen, Khanh Tran
Life of this patent
Estimating the term…
Abstract
A core-shell microneedle system and a method of manufacturing the microneedle system provides a pulsatile drug delivery system which is programmed to release drugs/vaccines at predictable times using biodegradable polymers and with controllable dosages. This microneedle system can be fully embedded into the skin and then release drugs/vaccines as sharp bursts in a timely manner, similar to multiple bolus injections.
Claims11
A drug delivery system comprising:
- an assembly including
- a substrate, and
- a plurality of microneedles extending from the substrate, each microneedle including:
- a shell including a biodegradable polymer, said shell having a tapered shape from a distal tip to a proximal base having a diameter larger than the distal tip,
- a core including a mixture of a therapeutic agent and a polymeric carrier,
- and
- a cap including a biodegradable polymer, the cap bonded to the base of the shell and enclosing the core within the shell, said cap and shell not including any therapeutic agent, and
- said assembly comprising:
- a water-soluble polymer layer between the cap and the substrate, said water-soluble polymer layer connecting the microneedles to the substrate with the tips of the microneedles directed away from the substrate,
- wherein the water-soluble polymer layer is configured to dissolve to release the microneedles from the substrate when the microneedles are inserted into the skin of a patient, leaving the microneedles embedded in the skin where the cap and shell of each of the plurality of microneedles degrade at a predetermined time to release the therapeutic agent therein into the skin of the patient.
7 more elements
Dependencies are inferred from the claim text.